The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors

Nhan Tran, Wendy S. McDonough, Patrick J. Donohue, Jeffrey A. Winkles, Theresa J. Berens, Kristen R. Ross, Dominique B. Hoelzinger, Christian Beaudry, Stephen W. Coons, Michael E. Berens

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Glioblastoma multiforme comprises the majority of human brain tumors. Patients with glioblastoma multiforme have poor survival rates, with an average life expectancy of <1 year. To assess possible mechanisms and to potentially target invasive glioma cells, we previously measured the gene expression profiles of glioma cells under migration-activated or passive states. One of the genes identified was Fn14, which encodes a cell surface receptor for the tumor necrosis factor superfamily member named TWEAK. In this study, we show that Fn14 gene expression is induced in migration-activated glioma cells in vitro and significantly increases according to tumor grade in vivo (P<0.01), with highest levels in glioblastoma tissue specimens. The in situ expression pattern of Fn14 mRNA and protein was confined to primary glioma cells and the vascular endothelium, with no detection in adjacent normal brain. Conversely, TWEAK mRNA levels are low in glioblastoma samples relative to normal brain tissue. In addition, activation of the Fn14 receptor by addition of recombinant TWEAK resulted in increased glioma cell migration in vitro. These results suggest a positive role for TWEAK and Fn14 in glioma progression and indicate that Fn14 gene expression may serve as a marker for invasive glioma cells.

Original languageEnglish (US)
Pages (from-to)1313-1321
Number of pages9
JournalAmerican Journal of Pathology
Volume162
Issue number4
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Glioma
Neuroglia
Glioblastoma
Genes
Neoplasms
Cell Movement
Gene Expression
Messenger RNA
Vascular Endothelium
Brain
Cell Surface Receptors
Life Expectancy
In Vitro Techniques
Transcriptome
Brain Neoplasms
Survival Rate
Tumor Necrosis Factor-alpha
Proteins

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Tran, N., McDonough, W. S., Donohue, P. J., Winkles, J. A., Berens, T. J., Ross, K. R., ... Berens, M. E. (2003). The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. American Journal of Pathology, 162(4), 1313-1321.

The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. / Tran, Nhan; McDonough, Wendy S.; Donohue, Patrick J.; Winkles, Jeffrey A.; Berens, Theresa J.; Ross, Kristen R.; Hoelzinger, Dominique B.; Beaudry, Christian; Coons, Stephen W.; Berens, Michael E.

In: American Journal of Pathology, Vol. 162, No. 4, 01.04.2003, p. 1313-1321.

Research output: Contribution to journalArticle

Tran, N, McDonough, WS, Donohue, PJ, Winkles, JA, Berens, TJ, Ross, KR, Hoelzinger, DB, Beaudry, C, Coons, SW & Berens, ME 2003, 'The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors', American Journal of Pathology, vol. 162, no. 4, pp. 1313-1321.
Tran, Nhan ; McDonough, Wendy S. ; Donohue, Patrick J. ; Winkles, Jeffrey A. ; Berens, Theresa J. ; Ross, Kristen R. ; Hoelzinger, Dominique B. ; Beaudry, Christian ; Coons, Stephen W. ; Berens, Michael E. / The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. In: American Journal of Pathology. 2003 ; Vol. 162, No. 4. pp. 1313-1321.
@article{4173b70765b0461ca5d29af8bb32c81f,
title = "The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors",
abstract = "Glioblastoma multiforme comprises the majority of human brain tumors. Patients with glioblastoma multiforme have poor survival rates, with an average life expectancy of <1 year. To assess possible mechanisms and to potentially target invasive glioma cells, we previously measured the gene expression profiles of glioma cells under migration-activated or passive states. One of the genes identified was Fn14, which encodes a cell surface receptor for the tumor necrosis factor superfamily member named TWEAK. In this study, we show that Fn14 gene expression is induced in migration-activated glioma cells in vitro and significantly increases according to tumor grade in vivo (P<0.01), with highest levels in glioblastoma tissue specimens. The in situ expression pattern of Fn14 mRNA and protein was confined to primary glioma cells and the vascular endothelium, with no detection in adjacent normal brain. Conversely, TWEAK mRNA levels are low in glioblastoma samples relative to normal brain tissue. In addition, activation of the Fn14 receptor by addition of recombinant TWEAK resulted in increased glioma cell migration in vitro. These results suggest a positive role for TWEAK and Fn14 in glioma progression and indicate that Fn14 gene expression may serve as a marker for invasive glioma cells.",
author = "Nhan Tran and McDonough, {Wendy S.} and Donohue, {Patrick J.} and Winkles, {Jeffrey A.} and Berens, {Theresa J.} and Ross, {Kristen R.} and Hoelzinger, {Dominique B.} and Christian Beaudry and Coons, {Stephen W.} and Berens, {Michael E.}",
year = "2003",
month = "4",
day = "1",
language = "English (US)",
volume = "162",
pages = "1313--1321",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors

AU - Tran, Nhan

AU - McDonough, Wendy S.

AU - Donohue, Patrick J.

AU - Winkles, Jeffrey A.

AU - Berens, Theresa J.

AU - Ross, Kristen R.

AU - Hoelzinger, Dominique B.

AU - Beaudry, Christian

AU - Coons, Stephen W.

AU - Berens, Michael E.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Glioblastoma multiforme comprises the majority of human brain tumors. Patients with glioblastoma multiforme have poor survival rates, with an average life expectancy of <1 year. To assess possible mechanisms and to potentially target invasive glioma cells, we previously measured the gene expression profiles of glioma cells under migration-activated or passive states. One of the genes identified was Fn14, which encodes a cell surface receptor for the tumor necrosis factor superfamily member named TWEAK. In this study, we show that Fn14 gene expression is induced in migration-activated glioma cells in vitro and significantly increases according to tumor grade in vivo (P<0.01), with highest levels in glioblastoma tissue specimens. The in situ expression pattern of Fn14 mRNA and protein was confined to primary glioma cells and the vascular endothelium, with no detection in adjacent normal brain. Conversely, TWEAK mRNA levels are low in glioblastoma samples relative to normal brain tissue. In addition, activation of the Fn14 receptor by addition of recombinant TWEAK resulted in increased glioma cell migration in vitro. These results suggest a positive role for TWEAK and Fn14 in glioma progression and indicate that Fn14 gene expression may serve as a marker for invasive glioma cells.

AB - Glioblastoma multiforme comprises the majority of human brain tumors. Patients with glioblastoma multiforme have poor survival rates, with an average life expectancy of <1 year. To assess possible mechanisms and to potentially target invasive glioma cells, we previously measured the gene expression profiles of glioma cells under migration-activated or passive states. One of the genes identified was Fn14, which encodes a cell surface receptor for the tumor necrosis factor superfamily member named TWEAK. In this study, we show that Fn14 gene expression is induced in migration-activated glioma cells in vitro and significantly increases according to tumor grade in vivo (P<0.01), with highest levels in glioblastoma tissue specimens. The in situ expression pattern of Fn14 mRNA and protein was confined to primary glioma cells and the vascular endothelium, with no detection in adjacent normal brain. Conversely, TWEAK mRNA levels are low in glioblastoma samples relative to normal brain tissue. In addition, activation of the Fn14 receptor by addition of recombinant TWEAK resulted in increased glioma cell migration in vitro. These results suggest a positive role for TWEAK and Fn14 in glioma progression and indicate that Fn14 gene expression may serve as a marker for invasive glioma cells.

UR - http://www.scopus.com/inward/record.url?scp=0037377706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037377706&partnerID=8YFLogxK

M3 - Article

VL - 162

SP - 1313

EP - 1321

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -